Wells Fargo’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-250
| Closed | -$3K | – | 7195 |
|
|
2021
Q3 | $3K | Hold |
250
| – | – | ﹤0.01% | 6478 |
|
|
2021
Q2 | $3K | Hold |
250
| – | – | ﹤0.01% | 6440 |
|
|
2021
Q1 | $4K | Hold |
250
| – | – | ﹤0.01% | 6529 |
|
|
2020
Q4 | $3K | Hold |
250
| – | – | ﹤0.01% | 6221 |
|
|
2020
Q3 | $5K | Hold |
250
| – | – | ﹤0.01% | 6011 |
|
|
2020
Q2 | $3K | Hold |
250
| – | – | ﹤0.01% | 6047 |
|
|
2020
Q1 | $2K | Hold |
250
| – | – | ﹤0.01% | 5984 |
|
|
2019
Q4 | $2K | Buy |
250
+242
| +3,025% | +$2.44K | ﹤0.01% | 6151 |
|
|
2019
Q3 | $0 | Sell |
8
-42
| -84% | -$466 | ﹤0.01% | 6361 |
|
|
2019
Q2 | $1K | Buy |
+50
| New | +$798 | ﹤0.01% | 6228 |
|
|
2018
Q2 | – | Sell |
-83
| Closed | -$2K | – | 6309 |
|
|
2018
Q1 | $2K | Hold |
83
| – | – | ﹤0.01% | 6181 |
|
|
2017
Q4 | $3K | Hold |
83
| – | – | ﹤0.01% | 6124 |
|
|
2017
Q3 | $2K | Hold |
83
| – | – | ﹤0.01% | 6138 |
|
|
2017
Q2 | $2K | Hold |
83
| – | – | ﹤0.01% | 6035 |
|
|
2017
Q1 | $3K | Hold |
83
| – | – | ﹤0.01% | 6105 |
|
|
2016
Q4 | $1K | Sell |
83
-75
| -47% | -$2K | ﹤0.01% | 6141 |
|
|
2016
Q3 | $7K | Hold |
158
| – | – | ﹤0.01% | 5832 |
|
|
2016
Q2 | $8K | Hold |
158
| – | – | ﹤0.01% | 5719 |
|
|
2016
Q1 | $4K | Sell |
158
-42
| -21% | -$1.4K | ﹤0.01% | 5895 |
|
|
2015
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 5752 |
|
|
2015
Q3 | $11K | Buy |
200
+25
| +14% | +$1.58K | ﹤0.01% | 5701 |
|
|
2015
Q2 | $12K | Hold |
175
| – | – | ﹤0.01% | 5746 |
|
|
2015
Q1 | $12K | Hold |
175
| – | – | ﹤0.01% | 5559 |
|
|
2014
Q4 | $18K | Buy |
175
+75
| +75% | +$8.11K | ﹤0.01% | 5398 |
|
|
2014
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 5473 |
|
|
2014
Q2 | $13K | Sell |
100
-17
| -15% | -$1.94K | ﹤0.01% | 5538 |
|
|
2014
Q1 | $20K | Buy |
117
+34
| +41% | +$18.8K | ﹤0.01% | 5223 |
|
|
2013
Q4 | $35K | Hold |
83
| – | – | ﹤0.01% | 4841 |
|
|
2013
Q3 | $21K | Hold |
83
| – | – | ﹤0.01% | 4940 |
|
|
2013
Q2 | $12K | Buy |
+83
| New | +$11.3K | ﹤0.01% | 5008 |
|
Other funds holding ATHE
TSS
CA
PCA
Wells Fargo's ATHE Position: Q4 2021 in Review
Wells Fargo sold out of Alterity Therapeutics (ATHE) in Q4 2021, closing a stake of 250 shares — an estimated $3K sold.
Wells Fargo first reported a position in ATHE in Q2 2013 and held it in 30 quarters. The position peaked at $35K in Q4 2013. 11 funds tracked by Wall St. Rank hold ATHE as of Q4 2021.
- Wells Fargo reported no remaining Alterity Therapeutics position as of Q4 2021 after selling out during the quarter.
- Wells Fargo sold 250 Alterity Therapeutics shares in Q4 2021, an estimated $3K.
- Wells Fargo first reported a position in Alterity Therapeutics in Q2 2013 and held it in 30 quarters.
- Wells Fargo's Alterity Therapeutics position peaked at $35K in Q4 2013.
- 11 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2021.
Based on Wells Fargo's 13F filing for Q4 2021, filed 14 Feb 2022.